#

IPO

: 404
Evommune IPO: shares in atopic dermatitis treatment developer become available
News·
Evommune IPO: shares in atopic dermatitis treatment developer become available
Main by morning: Google invests in Anthropic, Snap and Robinhood beat forecasts
News·
Main by morning: Google invests in Anthropic, Snap and Robinhood beat forecasts
Not on the agenda: OpenAI says it is not yet preparing for an IPO
News·
'Not on the agenda': OpenAI says it is not yet preparing for an IPO
Exzeo Group IPO: Insurance tech company debuts on NYSE
News·
+1
·
Exzeo Group IPO: Insurance tech company debuts on NYSE
Tesla of the skies Beta goes public on the Nasdaq
News·
+1
·
'Tesla of the skies' Beta goes public on the Nasdaq
OpenAIs $1 trillion listing and a rebound in the UK market: highlights of IPOs by Nov. 2
News·
OpenAI's $1 trillion listing and a rebound in the UK market: highlights of IPOs by Nov. 2
Just a normal company at $1 trillion: How OpenAI is making its way to the stock exchange
Review·
"Just a normal company" at $1 trillion: How OpenAI is making its way to the stock exchange
Israeli business-travel firm Navan goes public in U.S., trading opens
News·
+1
·
Israeli business-travel firm Navan goes public in U.S., trading opens
Highlights for the morning: Alphabet and Microsoft records, US-China deal, OpenAI IPO
News·
Highlights for the morning: Alphabet and Microsoft records, US-China deal, OpenAI IPO
OpenAI could have one of the largest IPOs in history in 2027 - WSJ
News·
OpenAI could have one of the largest IPOs in history in 2027 - WSJ
Novo-backed schizophrenia drugmaker MapLight Therapeutics debuts on Nasdaq
News·
+1
·
Novo-backed schizophrenia drugmaker MapLight Therapeutics debuts on Nasdaq
Listing of OpenAI competitor, Unilever and the Rivian trial: Whats important about the IPO by Oct. 26
News·
Listing of OpenAI competitor, Unilever and the Rivian trial: What's important about the IPO by Oct. 26
Load more